Assessing whether you have a genetic predisposition to obesity allows you to implement dietary and integrative strategies from a preventive perspective.
For a long time, ESR and CRP have been the primary biomarkers for assessing inflammation. However, these "acute-phase" proteins have limitations in specificity and sensitivity for identifying low-grade inflammation. Other biomarkers, such as BAFF and PAF, which are linked to specific immune pathways, are more accurate for this type of inflammation.
Preventing diabetes by identifying genetic predispositions and lifestyle factors can significantly add healthy years of life. A personalized medicine approach is crucial to enhance quality of life and well-being, allowing occasional indulgences without compromising health.